Stay updated on Personalized Neoantigen Cancer Vaccine Clinical Trial

Sign up to get notified when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Personalized Neoantigen Cancer Vaccine Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record for a completed Phase 1/2 study of a personalized neoantigen cancer vaccine is now displayed, including its treatment plan, eligibility criteria, outcomes, and study locations.
    Difference
    61%
    Check dated 2026-11-11T00:18:20.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:12:38.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:42:13.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:37:24.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    FDA-regulated product disclosures and a large set of drug/MeSH terms (including ipilimumab and nivolumab) were deleted. The deletions reduce visibility of the study’s immunotherapy components and regulatory context on the page.
    Difference
    19%
    Check dated 2026-09-22T23:47:27.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a new page build/version. This change represents a metadata update and does not modify study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-09-15T23:41:00.000Z thumbnail image

Stay in the know with updates to Personalized Neoantigen Cancer Vaccine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.